Who we are
Diversity and Inclusion
Penta Foundation Italy
Penta ID Innovation
News & Events
Penta Aperitivo Webinars
Work with us
Calls for service
Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases
Adherence to antiretroviral therapy in pregnancy and during the first year post-partum in HIV-positive women in Ukraine
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Effective exposure to atazanavir during pregnancy, regardless of tenofovir use
A comparison of the pharmacokinetics of raltegravir during pregnancy and postpartum
Low darunavir exposure during pregnancy with 800/100mg darunavir/r QD dosing
Uptake and outcomes of HCV treatment in children and young adults with HIV/HCV co-infection in Europe
Children living with HIV in Ukraine: response to antiretroviral therapy (ART) and duration of first-line regimens
Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
Pharmacokinetics of Pediatric Lopinavir/Ritonavir Tablets in Children When Administered Twice Daily According to FDA weight bands.
HIV-1 resistance after randomized virologic switch at 1,000 or 30,000 c/ml in children.
Moving on up: tracking young people with perinatal HIV as they transition to adult care in Europe
Double dosing of ritonavir in twice-daily darunavir-containing regimens: an example of a lack of appropriate formulations in paediatrics
Increasing abacavir use in HIV-1-infected pregnant women in Europe: effectiveness and safety data